间充质干细胞的制药用途

    公开(公告)号:CN112057471B

    公开(公告)日:2023-12-22

    申请号:CN202010954720.7

    申请日:2020-09-11

    Abstract: 本申请公开了间充质干细胞在制备药物中的用途,所述药物用于预防和/或治疗子宫内膜恶性增生疾病,所述间充质干细胞包括子宫内膜间充质干细胞。(56)对比文件郑丽红;胡晓丽;朱雪琼.子宫来源间充质干细胞对妇科恶性肿瘤生物学行为的影响.医学研究杂志.2019,第48卷(第03期),12-15.Yuhui Xu, Jiali Hu, Qiaoying Lv,Chenyi Shi, Mengdi Qiu, Liying Xie, WeiLiu, Bingyi Yang, Weiwei Shan, YaliCheng, Bing Zhao, Xiaojun Chen.Endometrium-derived mesenchymal stemcells suppress progression of endometrialcancer via the DKK1-Wnt/β-cateninsignaling pathway.Stem Cell Research &Therapy.2023,第14卷(第1期),159.Xin Li, Li Li Liu, Ju Lei Yao, KaiWang, Hao Ai.Human Umbilical CordMesenchymal Stem Cell-DerivedExtracellular Vesicles InhibitEndometrial Cancer Cell Proliferation andMigration through Delivery of ExogenousmiR-302a.Stem Cells International.2019,第2019卷摘要.Xin Li, Li Li Liu, Ju Lei Yao, KaiWang, Hao Ai.Human Umbilical CordMesenchymal Stem Cell-DerivedExtracellular Vesicles InhibitEndometrial Cancer Cell Proliferation andMigration through Delivery of ExogenousmiR-302a.Stem Cells International.2019,第2019卷摘要.

Patent Agency Ranking